LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation
J. Rousse, P.-J. Royer, G. Evanno, E. Lheriteau, C. Ciron, A. Salama, F. Shneiker, R. Duchi, A. Perota, C. Galli, E. Cozzi, G. Blancho, O. Duvaux, S. Brouard, J.-P. Soulillou, , B. Vanhove
The paper describes LIS1, a glyco-humanized anti-lymphocyte globulin, as a novel induction therapy for solid organ transplantation that reduces immunogenicity and T-cell depletion while maintaining immunosuppression.
Frontiers in Immunology · Feb 16, 2023Peer-reviewedImmunology